The history of the erectile dysfunction drug presents a intricate picture for shareholders. While the initial introduction generated substantial gains, the lapse of its intellectual property protection opened the https://baidubookmark.com/story21474664/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet